CYTK
Price
$63.37
Change
+$2.05 (+3.34%)
Updated
May 1, 6:59 PM EST
7 days until earnings call
INMB
Price
$11.60
Change
-$0.24 (-2.03%)
Updated
May 1, 6:59 PM EST
Earnings call today
Ad is loading...

Compare trend and price CYTK vs INMB

Header iconCYTK vs INMB Comparison
Open Charts CYTK vs INMBBanner chart's image
Cytokinetics
Price$63.37
Change+$2.05 (+3.34%)
Volume$677.33K
CapitalizationN/A
INmune Bio
Price$11.60
Change-$0.24 (-2.03%)
Volume$131.85K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs INMB Comparison Chart

Loading...

CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CYTK vs. INMB commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and INMB is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (CYTK: $61.32 vs. INMB: $11.84)
Brand notoriety: CYTK and INMB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 119% vs. INMB: 372%
Market capitalization -- CYTK: $6.41B vs. INMB: $222.3M
CYTK [@Biotechnology] is valued at $6.41B. INMB’s [@Biotechnology] market capitalization is $222.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while INMB’s TA Score has 6 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 6 bearish.
  • INMB’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, INMB is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -6.48% price change this week, while INMB (@Biotechnology) price change was +16.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was -4.20%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

CYTK is expected to report earnings on Aug 01, 2024.

INMB is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for INMB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($6.41B) has a higher market cap than INMB($222M). INMB YTD gains are higher at: 5.151 vs. CYTK (-26.554).
CYTKINMBCYTK / INMB
Capitalization6.41B222M2,889%
EBITDAN/AN/A-
Gain YTD-26.5545.151-516%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKINMB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
77%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSIG46.23-0.08
-0.17%
Goldman Sachs Acs Inv Gd Cp 1-5Yr Bd ETF
IBND28.45-0.25
-0.87%
SPDR® Blmbg Intl Corp Bd ETF
NORW24.45-0.33
-1.33%
Global X MSCI Norway ETF
CGGR30.34-0.56
-1.81%
Capital Group Growth ETF
UCO32.92-0.75
-2.23%
ProShares Ultra Bloomberg Crude Oil

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+0.59%
MDGL - INMB
41%
Loosely correlated
+1.47%
ORMP - INMB
38%
Loosely correlated
-4.72%
AXON - INMB
37%
Loosely correlated
+0.11%
CYTK - INMB
34%
Loosely correlated
-1.94%
AUTL - INMB
33%
Loosely correlated
-3.16%
More